SEC Company Response from 908 Devices (MASS) — Nov 8, 2021
908 Devices Inc.
Date: Nov. 8, 2021 · CIK: 0001555279 · Accession: 0001104659-21-135700
AI Filing Summary & Sentiment
File numbers found in text: 333-260865
Letter
Re: 908 Devices Inc.
November 8, 2021
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-260865)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), 908 Devices Inc. (the “Company”) hereby requests that the effective date and time of the above-referenced registration statement (the “Registration Statement”) be accelerated to November 10, 2021 at 4:01 p.m., Eastern Time, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Evyn W. Rabinowitz at (212) 459-7146. We also respectfully request that a copy of the written order from the Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Evyn W. Rabinowitz.
Under separate cover, Cowen and Company, LLC and SVB Leerink LLC, as representatives of the underwriters, will send the Commission a letter joining in this request for acceleration of the effective date. The representatives will also provide you with information with respect to clearance from the Financial Industry Regulatory Authority prior to the effective date.
[Signature page follows]
If you have any questions regarding this request, please contact Evyn W. Rabinowitz of Goodwin Procter LLP at (212) 459-7146.
Sincerely,
908 DEVICES INC.
Show Raw Text
CORRESP
1
filename1.htm
November 8, 2021
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: 908 Devices Inc.
Registration Statement on Form S-1 (File No. 333-260865)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act
of 1933, as amended (the “Act”), 908 Devices Inc. (the “Company”) hereby requests that the effective date and
time of the above-referenced registration statement (the “Registration Statement”) be accelerated to November 10, 2021 at
4:01 p.m., Eastern Time, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the
Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). In making this acceleration
request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective,
please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Evyn W. Rabinowitz at (212) 459-7146. We also respectfully
request that a copy of the written order from the Commission verifying the effective time and date of the Registration Statement be sent
to our counsel, Goodwin Procter LLP, Attention: Evyn W. Rabinowitz.
Under separate cover, Cowen and Company, LLC and
SVB Leerink LLC, as representatives of the underwriters, will send the Commission a letter joining in this request for acceleration of
the effective date. The representatives will also provide you with information with respect to clearance from the Financial Industry Regulatory
Authority prior to the effective date.
[Signature page follows]
If you have any questions regarding this request,
please contact Evyn W. Rabinowitz of Goodwin Procter LLP at (212) 459-7146.
Sincerely,
908 DEVICES INC.
By:
/s/ Kevin J. Knopp
Name: Kevin J. Knopp
Title: Chief Executive Officer and Director
cc: Joseph H. Griffith IV, Chief Financial
Officer, 908 Devices Inc.
Michael S. Turner, Vice President,
General Counsel, 908 Devices, Inc.
Michael J. Minahan, Esq.,
Goodwin Procter LLP
Evyn W. Rabinowitz, Esq.,
Goodwin Procter LLP
[Signature Page to 908 Devices Inc. Acceleration Request]